Anu R I

Fabulous moments! Humbled beyond words... @kaelin_lab and @DrSarcoma at @HarvardClub374

@ajumathew_ The power of currency value

Oncotype - cost effective?

Hallmarks of cancer-Then and now, and beyond (2026) ➡️Culminating with #multiomics and #cotargeting cell.com/cell/fulltext/… It was an honour to discuss extent of #hallmarks with Prof Hanahan few days ago! @CellPressNews

@JayantYGadrey6 @harvardmed @DanaFarber Indeed. Methods of critical thinking, problem solving, future of precision oncology, developing hypotheses were some of the areas discussed. Above all, he was exceptionally kind.

@anu_iris @harvardmed @DanaFarber Must’ve been an inspiring chat and an incredible opportunity to get pearls of wisdom directly from him!

2019: At Harvard, was thrilled to listen to Prof William G. Kaelin when he was awarded the Nobel Prize in Medicine 2026: I get the opportunity to discuss my work and receive guidance Grateful to be conceptually imprinted like so! @harvardmed @DanaFarber

Interpreting the results of noninferiority trials—a review British Journal of Cancer doi.org/10.1038/s41416… 👏great review 👉option of define advantage beyond efficacy 👉Key is to define clinical noninferiority margin 👉determining its efficacy versus no treatment can be a challenge @myESMO @ASCO

Kaushal et al. share EIOC guidelines on liquid biopsy and targeted therapy for early-stage & locally advanced NSCLC in the Middle East and the Indian subcontinent, emphasizing combined liquid+tissue testing for actionable mutations. Read more: bit.ly/3KvGw6S #MedTwitter

Rewriting epigenetic memory in mouse sperm— allowing erasal of DNA methylation at H19🧬 The result: Offspring with Silver-Russell-like traits 》》》Intergenerational epigenetic inheritance #Epigenetics #Genetics #Inheritance #Science nature.com/articles/s4146…

@pedromics this one is funny! 😅

@RyanTScott @esa @KeithSiew @NatureComms @NASA @BrookhavenLab @mason_lab Ha! Nice comparison 😃

Some space science art. Crater in Quebec seen from @esa satellite to microscopy of rodent kidney glomerulus, from @KeithSiew et al 2024 PMID: 38862484 @NatureComms exposed to simulated Galactic Cosmic Rays at @NASA Space Radiation Laboratory @BrookhavenLab @mason_lab @AfshinBeheshti @NASAGeneLab @NASAScience_ @ASGSRSpace

Glad to be interviewed by @LisaSpiteri13 🙏 #NETondemand #Malta #LiveTelevision🔥 Speaking to tge public on our most recent #cancerresearch project🎗 Link: netondemand.mt/play/35155 Timestamp: 1:02:00 onwards #precisiononcology #treatmentresistance #oncology

@OdedRechavi 😂

When your PI presents your work

Happy to be a part of Excellence in oncology care (EIOC) consensus guidelines on #liquidbiopsy and #targetedtherapy in early-stage and locally advanced non-small cell #lungcancer (#NSCLC) for #MiddleEast & #India @CRSTonline @VanitaNoronha @kumarprabhash

🗣Honoured to speak at SYNAPSE25: #AI & #MolecularOncology Organized by Indian Society for Medical and Pediatric Oncology and @IITGuwahati #India 📢FOCUS>>Therapeutic resistance>>Multiomics #cancerresearch #UNet #LLM #bioinformatics #pathology #multiomics

@Dr_R_Kurzrock Hearty congratulations!

Honored to be on the “list” Actually have been listed for several years, except for 2022, when they misspelled my name. How does a computer make a typo? Regardless, mostly I hope we make an impact for patients

TRENDS: From #ASCO to #ESMO 2025: major shifts in cancer trials. The future of #oncology is Precision>>Earlier>>Smarter. #CancerResearch #ClinicalTrials #LiquidBiopsy #Immunotherapy #ADC #PrecisionOncology #AIinHealthcare

@Amolpatel_dr @SidYadavMD @dr_rajapramanik @hoperugo Having said that, there is no concept of mutual exclusivity in biology. Its merely a probability score. Choice of TT would depend on the tumor profile in its entirety>>> personalized in every sense.

@anu_iris @SidYadavMD @dr_rajapramanik @hoperugo That sounds pretty cool… You nailed it, the real question in my mind how such observations can be explored for therapeutic arena? I am sure @anu_iris you will have some hypothesis.

Why Her2neu positive subtype is not known in BRCA positive breast cancers ? @SidYadavMD @dr_rajapramanik @hoperugo

🌍 New @NatureMedicine review WHO’s global analysis of 89,000+ #cancertrials reveals deep inequities! 70% in HICs & <7% in Africa/Asia. Deadliest cancers (liver, stomach, pancreas, cervix) under-studied. #CancerResearch #WHO #ESMO #ASCO

@BoyiGan @NatureRevCancer Insightful paper! Congratulations!

Our new review article in @NatureRevCancer discussing targeting metabolic cell death (#ferroptosis, #cuproptosis and #disulfidptosis) in cancer nature.com/articles/s4156…; rdcu.be/eK7vV